SGMO - Sangamo Therapeutics Inc. (SGMO) Q1 2024 Earnings Call Transcript
2024-05-09 19:13:12 ET
Sangamo Therapeutics, Inc. (SGMO)
Q1 2024 Earnings Conference Call
May 9, 2024 4:30 PM ET
Company Participants
Louise Wilkie - Vice President, Investor Relations and Corporate Communications
Sandy Macrae - Chief Executive Officer
Amy Pooler - Head of Research
Nathalie Dubois-Stringfellow - Chief Development Officer
Conference Call Participants
James Stamos - Jefferies
Gena Wang - Barclays
Luis Santos - H.C. Wainwright
Ritu Baral - TD Cowen
Bill Chappell - Truist
Presentation
Operator
Good day, and welcome to the Sangamo Therapeutics First Quarter 2024 Teleconference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today’s conference is being recorded.
I would now like to turn the conference over to your speaker today, Louise Wilkie, Vice President of Investor Relations and Corporate Communications. Please go ahead.
Louise Wilkie
Thank you. Good afternoon, everyone. Thank you for joining us on the call today.
On this call are several members of the Sangamo executive leadership team, including Sandy Macrae, Chief Executive Officer; Prathyusha Duraibabu, Chief Financial Officer; Amy Pooler, Head of Research; Nathalie Dubois-Stringfellow, Chief Development Officer....
Sangamo Therapeutics, Inc. (SGMO) Q1 2024 Earnings Call Transcript